Your browser doesn't support javascript.
loading
Genetic mutations associated with lung cancer metastasis to the brain.
Aljohani, Hashim M; Aittaleb, Mohamed; Furgason, John M; Amaya, Peter; Deeb, Ayham; Chalmers, Jeffery J; Bahassi, El Mustapha.
Afiliação
  • Aljohani HM; Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA.
  • Aittaleb M; Department of Molecular Genetics and Biochemistry, Cincinnati, OH, USA.
  • Furgason JM; Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA.
  • Amaya P; Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA.
  • Deeb A; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
  • Chalmers JJ; William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Koffolt Lab, CBEC, Columbus, OH, USA.
  • Bahassi EM; Department of Internal Medicine, Division of Hematology and Oncology and UC Brain Tumor Center, Cincinnati, OH, USA.
Mutagenesis ; 33(2): 137-145, 2018 04 13.
Article em En | MEDLINE | ID: mdl-29474635
ABSTRACT
Approximately 90% of all cancer deaths arise from the metastatic spread of primary tumours. Of all the processes involved in carcinogenesis, local invasion and the formation of metastases are clinically the most relevant, but they are the least well understood at the molecular level. As a barrier to metastasis, cells normally undergo an apoptotic process known as 'anoikis', in circulation. The recent technological advances in the isolation and characterisation of rare circulating tumour cells (CTCs) will allow a better understanding of anoikis resistance. Detailed molecular and functional analyses of anoikis-resistant cells may provide insight into the biology of cancer metastasis and help identify novel targets for prevention of cancer dissemination. To uncover the molecular changes that govern the transition from a primary lung tumour to a secondary metastasis and specifically the mechanisms by which CTCs survive in circulation, we carried out whole genome sequencing (WGS) of normal lung, primary tumours and the corresponding brain metastases from five patients with progressive metastatic non-small-cell lung carcinoma. We also isolated CTCs from patients with metastatic cancer and subjected them to whole genome amplification and Sanger sequencing of genes of interest. While the primary tumours showed mutations in genes associated with cell adhesion and motility, brain metastases acquired mutations in adaptive, cytoprotective genes involved in response to cellular stress such as Keap-1, Nrf2 and P300, which are key players of the Keap1-Nrf2-ARE survival pathway. Nrf2 is a transcriptional factor that upon stress translocates into the nucleus, binds to the anti-oxidant response elements (ARE) and drives the expression of anti-oxidant genes. The identified mutations affect regulatory domains in all three proteins, suggesting a functional role in providing a survival advantage to CTCs in the peripheral blood allowing their dissemination to distant organs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteína p300 Associada a E1A / Fator 2 Relacionado a NF-E2 / Proteína 1 Associada a ECH Semelhante a Kelch / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Proteína p300 Associada a E1A / Fator 2 Relacionado a NF-E2 / Proteína 1 Associada a ECH Semelhante a Kelch / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article